Quick Answer
Tectonic Therapeutic, Inc. reported Stockholders Equity of $251.33 million for the year ending 2025.
- Tectonic Therapeutic, Inc. showed an increase of +78.5% in Stockholders Equity from 2024 to 2025.
- This data is from Tectonic Therapeutic, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$33.51 million | Q2 2018: $148.32 million | Q3 2018: $137.11 million | Q1 2019: $106.79 million | Q2 2019: $92.63 million | Q3 2019: $206.76 million | Q1 2020: $256.53 million | Q2 2020: $239.79 million | Q3 2020: $207.87 million | Q1 2021: $232.93 million | Q2 2021: $220.99 million | Q3 2021: $193.57 million | Q1 2022: $143.16 million | Q2 2022: $118.34 million | Q3 2022: $98.09 million | Q1 2023: -$59.82 million | Q2 2023: -$70.00 million | Q3 2023: -$79.78 million | Q1 2024: -$99.57 million | Q2 2024: $166.37 million | Q3 2024: $150.36 million | Q1 2025: $301.04 million | Q2 2025: $283.77 million | Q3 2025: $267.53 million.
- Over the full 10 years of available data (2016 to 2025), Tectonic Therapeutic, Inc.'s Stockholders Equity has grown by 5,588.7%.
- Historical annual values: Fiscal year 2025: $251.33 million | Fiscal year 2024: $140.78 million | Fiscal year 2023: -$84.64 million | Fiscal year 2022: -$45.65 million | Fiscal year 2021: $169.48 million | Fiscal year 2020: $254.34 million | Fiscal year 2019: $186.01 million | Fiscal year 2018: $122.18 million | Fiscal year 2017: -$23.14 million | Fiscal year 2016: -$4.58 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: